|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
|||||||
|
|||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=sE9DDEF18-6070-11EF-82FE-522585CE164B&I=39IZM&T=&OP=Display&O=html&O1=15907331&O2=4520000000000844&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DFixed-Duration%2520Ibrutinib-Venetoclax%2520in%2520Patients%2520with%2520Chronic%2520Lymphocytic%2520Leukemia%2520and%2520Comorbidities%26rft.au%3DKater%252C%2520Arnon%2520P%26rft.date%3D2022-07-01%26rft.eissn%3D2766-5526%26rft.epage%3DEVIDoa2200006%26rft.externalDBID%3DNO_FULL_TEXT%26rft.genre%3Darticle%26rft.issue%3D7%26rft.jtitle%3DNEJM%2520evidence%26rft.spage%3DEVIDoa2200006%26rft.volume%3D1%26rft_id%3Dinfo%253Adoi%252F10.1056%252FEVIDoa2200006%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-OVID_JOURNALS_AT_OVID-getFullTxt-object,2-DOI-getDOI-object,3-COBIB_SI_LCL-getHolding-object,4-REFWORKS_EXPORT_TOOL-getReference-object,5-GOOGLE_SCHOLAR_FREE-getWebSearch-object,6-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.310895&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15907331-sE9DDEF18-6070-11EF-82FE-522585CE164B" timestamp="2024-08-22T12:25:55Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:4520000000000844</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Fixed-Duration Ibrutinib-Venetoclax in Patients with Chronic Lymphocytic Leukemia and Comorbidities</jnl:atitle>
<jnl:jtitle>NEJM Evidence</jnl:jtitle>
<jnl:date>2022-06-28</jnl:date>
<jnl:spage>EVIDoa2200006</jnl:spage>
<jnl:epage>EVIDoa2200006</jnl:epage>
<jnl:issn>2766-5526</jnl:issn>
<jnl:volume>1</jnl:volume>
<jnl:issue>7</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>2766-5526</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:37b1695dee28594992a01c77aa918ca150b88693</ctx:identifier>
<ctx:identifier>urn:UUID:sE9DDEF18-6070-11EF-82FE-522585CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)